{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T03:08:52Z","timestamp":1784689732009,"version":"3.55.0"},"reference-count":87,"publisher":"Elsevier BV","issue":"3-4","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annales d'Endocrinologie"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.ando.2020.02.003","type":"journal-article","created":{"date-parts":[[2020,2,28]],"date-time":"2020-02-28T16:06:24Z","timestamp":1582905984000},"page":"151-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Cardiovascular consequences of parathyroid disorders in adults"],"prefix":"10.1016","volume":"82","author":[{"given":"Jens","family":"Bollerslev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelina","family":"Sj\u00f6stedt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Rejnmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.ando.2020.02.003_bib0440","doi-asserted-by":"crossref","first-page":"P1","DOI":"10.1530\/EJE-19-0316","article-title":"Management of endocrine disease: unmet therapeutic, educational and scientific needs in parathyroid disorders","volume":"181","author":"Bollerslev","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.02.003_bib0445","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S0140-6736(09)60507-9","article-title":"Hyperparathyroidism","volume":"374","author":"Fraser","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2020.02.003_bib0450","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S0140-6736(97)12331-5","article-title":"Electrolyte quintet: calcium","volume":"352","author":"Bushinsky","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/j.ando.2020.02.003_bib0455","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/j.beem.2018.06.005","article-title":"Parathyroid hormone independent hypercalcemia in adults","volume":"32","author":"Bollerslev","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0460","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.bone.2003.06.001","article-title":"Large calcium fluxes that are not related to remodeling exist","volume":"33","author":"Parfitt","year":"2003","journal-title":"Bone"},{"key":"10.1016\/j.ando.2020.02.003_bib0465","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1073\/pnas.89.7.2732","volume":"89","author":"Abou-Samra","year":"1992","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ando.2020.02.003_bib0470","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhlen","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.ando.2020.02.003_bib0475","doi-asserted-by":"crossref","first-page":"15455","DOI":"10.1074\/jbc.270.26.15455","article-title":"Identification and functional expression of a receptor selectively recognizing parathyroid hormone, the PTH2 receptor","volume":"270","author":"Usdin","year":"1995","journal-title":"J Biol Chem"},{"key":"10.1016\/j.ando.2020.02.003_bib0480","first-page":"2149","article-title":"Serum calcium and survival in a large health screening program","volume":"81","author":"Leifsson","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0485","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/S0895-4356(97)00104-2","article-title":"Serum calcium: a new, independent, prospective risk factor for myocardial infarction in middle-aged men followed for 18 years","volume":"50","author":"Lind","year":"1997","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.ando.2020.02.003_bib0490","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1161\/01.HYP.34.3.484","article-title":"Serum calcium and cardiovascular risk factors and diseases: the Tromso study","volume":"34","author":"Jorde","year":"1999","journal-title":"Hypertension"},{"key":"10.1016\/j.ando.2020.02.003_bib0495","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1161\/CIRCULATIONAHA.108.808733","article-title":"Plasma parathyroid hormone and the risk of cardiovascular mortality in the community","volume":"119","author":"Hagstrom","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.ando.2020.02.003_bib0500","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1093\/eurheartj\/ehq109","article-title":"Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography","volume":"31","author":"Pilz","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/j.ando.2020.02.003_bib0505","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12020-017-1374-6","article-title":"The intriguing connections of leptin to hyperparathyroidism","volume":"57","author":"Polyzos","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/j.ando.2020.02.003_bib0510","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1038\/s41574-018-0042-0","article-title":"Diagnosis and management of pseudohypoparathyroidism and related disorders: first international Consensus Statement","volume":"14","author":"Mantovani","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/j.ando.2020.02.003_bib0515","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0039-6060(97)90357-3","article-title":"Population-based screening for primary hyperparathyroidism with serum calcium and parathyroid hormone values in menopausal women","volume":"121","author":"Lundgren","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2020.02.003_bib0520","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1210\/jc.2007-0600","article-title":"Disturbances of calcium homeostasis consistent with mild primary hyperparathyroidism in premenopausal women and associated morbidity","volume":"93","author":"Siilin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0525","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-15-0628","article-title":"European Society of Endocrinology Clinical Guideline: treatment of chronic hypoparathyroidism in adults","volume":"173","author":"Bollerslev","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.02.003_bib0530","first-page":"863","article-title":"Seventeen year follow-up study of bone mass in patients with mild asymptomatic hyperparathyroidism some of whom were operated on","volume":"161","author":"Elvius","year":"1995","journal-title":"Eur J Surg"},{"issue":"9","key":"10.1016\/j.ando.2020.02.003_bib0535","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of Surgery Versus Observation: Skeletal 5-Year Outcomes in a Randomized Trial of Patients With Primary HPT (the SIPH Study)","volume":"32","author":"Lundstam","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2020.02.003_bib0540","doi-asserted-by":"crossref","first-page":"3462","DOI":"10.1210\/jc.2007-1215","article-title":"The natural history of primary hyperparathyroidism with or without parathyroid surgery after 15 years","volume":"93","author":"Rubin","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"issue":"6","key":"10.1016\/j.ando.2020.02.003_bib0545","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/cen.12291","article-title":"The important players in primary hyperparathyroidism","volume":"79","author":"Bollerslev","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.02.003_bib0550","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/cen.12206","article-title":"What predicts adverse outcomes in untreated primary hyperparathyroidism? The Parathyroid Epidemiology and Audit Research Study (PEARS)","volume":"79","author":"Yu","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.02.003_bib0555","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1210\/jc.2004-1400","article-title":"Arterial stiffness in mild primary hyperparathyroidism","volume":"90","author":"Rubin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0560","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1365-2265.2010.03909.x","article-title":"Effect of surgery on cardiac structure and function in mild primary hyperparathyroidism","volume":"74","author":"Persson","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.02.003_bib0565","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-11-0589","article-title":"Current evidence for recommendation of surgery, medical treatment and vitamin D repletion in mild primary hyperparathyroidism","volume":"165","author":"Bollerslev","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.02.003_bib0570","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/s00268-002-6541-z","article-title":"Cardiovascular events before and after surgery for primary hyperparathyroidism","volume":"27","author":"Vestergaard","year":"2003","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2020.02.003_bib0575","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0580","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1210\/jc.2012-1429","article-title":"The importance of measuring ionized calcium in characterizing calcium status and diagnosing primary hyperparathyroidism","volume":"97","author":"Ong","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0585","first-page":"1","article-title":"Mortality after surgery for primary hyperparathyroidism: a follow-up of 441 patients operated on from 1956 to 1979","volume":"102","author":"Palmer","year":"1987","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2020.02.003_bib0590","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1007\/BF01670531","article-title":"Premature death in patients operated on for primary hyperparathyroidism","volume":"14","author":"Hedback","year":"1990","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2020.02.003_bib0595","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s00268-003-7046-0","article-title":"Increased mortality in patients hospitalized with primary hyperparathyroidism during the period 1977-1993 in Denmark","volume":"28","author":"Ogard","year":"2004","journal-title":"World J Surg"},{"key":"10.1016\/j.ando.2020.02.003_bib0600","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0039-6060(97)90216-6","article-title":"Survival after surgical treatment for primary hyperparathyroidism","volume":"122","author":"Soreide","year":"1997","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2020.02.003_bib0605","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S0002-9343(97)00270-2","article-title":"Survival after the diagnosis of hyperparathyroidism: a population-based study","volume":"104","author":"Wermers","year":"1998","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2020.02.003_bib0610","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1056\/NEJM199005313222203","article-title":"Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study","volume":"322","author":"Levy","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ando.2020.02.003_bib0615","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1067\/msy.2000.110240","article-title":"Left ventricular systolic and diastolic function and exercise testing in primary hyperparathyroidism-effects of parathyroidectomy","volume":"128","author":"Nilsson","year":"2000","journal-title":"Surgery"},{"key":"10.1016\/j.ando.2020.02.003_bib0620","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000007031","article-title":"Left ventricular structure and function in primary hyperparathyroidism before and after parathyroidectomy","volume":"93","author":"Nappi","year":"2000","journal-title":"Cardiology"},{"key":"10.1016\/j.ando.2020.02.003_bib0625","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1210\/jc.2009-2072","article-title":"Cardiac structure and diastolic function in mild primary hyperparathyroidism","volume":"95","author":"Walker","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0630","doi-asserted-by":"crossref","first-page":"4399","DOI":"10.1210\/jc.2015-3202","article-title":"Effect of parathyroidectomy upon left ventricular mass in primary hyperparathyroidism: a meta-analysis","volume":"100","author":"McMahon","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0635","doi-asserted-by":"crossref","first-page":"R297","DOI":"10.1530\/EJE-17-0485","article-title":"Cardiovascular manifestations of primary hyperparathyroidism: a narrative review","volume":"177","author":"Pepe","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.02.003_bib0640","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ijcard.2016.11.080","article-title":"Primary hyperparathyroidism predicts hypertension: results from the National Inpatient Sample","volume":"227","author":"Kalla","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ando.2020.02.003_bib0645","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1080\/10641963.2019.1590388","article-title":"Morning blood pressure surge increases in patients with hypertensive primary hyperparathyroidism and is independently associated with serum calcium level","volume":"42","author":"Demirtas","year":"2020","journal-title":"Clin Exp Hypertens"},{"key":"10.1016\/j.ando.2020.02.003_bib0650","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1210\/jc.2004-1891","article-title":"Association between primary hyperparathyroidism and increased body weight: a meta-analysis","volume":"90","author":"Bolland","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0655","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.ijcard.2008.12.027","article-title":"Effect of successful parathyroidectomy on 24-hour ambulatory blood pressure in patients with primary hyperparathyroidism","volume":"142","author":"Rydberg","year":"2010","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.ando.2020.02.003_bib0660","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.surg.2005.02.001","article-title":"Maintained normalization of cardiovascular dysfunction 5 years after parathyroidectomy in primary hyperparathyroidism","volume":"137","author":"Nilsson","year":"2005","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.ando.2020.02.003_bib0665","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamasurg.2019.3950","article-title":"Parathyroidectomy for patients with primary hyperparathyroidism and associations with hypertension","volume":"155","author":"Graff-Baker","year":"2020","journal-title":"JAMA surgery"},{"key":"10.1016\/j.ando.2020.02.003_bib0670","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1210\/jc.2018-02456","article-title":"Effect of parathyroidectomy on cardiovascular risk factors in primary hyperparathyroidism: a randomized clinical trial","volume":"104","author":"Ejlsmark-Svensson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0675","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1210\/jc.2014-3441","article-title":"Effects of parathyroidectomy versus observation on the development of vertebral fractures in mild primary hyperparathyroidism","volume":"100","author":"Lundstam","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0680","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2006-1836","article-title":"Medical observation, compared with parathyroidectomy, for asymptomatic primary hyperparathyroidism: a prospective, randomized trial","volume":"92","author":"Bollerslev","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0685","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1210\/jc.2019-00143","article-title":"PTH modulation by aldosterone and angiotensin II is blunted in hyperaldosteronism and rescued by adrenalectomy","volume":"104","author":"Lenzini","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0690","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.amjsurg.2019.10.032","article-title":"Comparative prospective study on the presentation of normocalcemic primary hyperparathyroidism. Is it more aggressive than the hypercalcemic form?","volume":"219","author":"Gomez-Ramirez","year":"2020","journal-title":"Am J Surg"},{"key":"10.1016\/j.ando.2020.02.003_bib0695","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","article-title":"Management of normocalcemic primary hyperparathyroidism","volume":"32","author":"Cusano","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0700","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1515\/cclm-2013-0315","article-title":"Sampling and storage conditions influencing the measurement of parathyroid hormone in blood samples: a systematic review","volume":"51","author":"Hanon","year":"2013","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.ando.2020.02.003_bib0705","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1210\/jc.2017-02773","article-title":"Pro-FHH: a risk equation to facilitate the diagnosis of parathyroid-related hypercalcemia","volume":"103","author":"Bertocchio","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0710","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12872-019-1093-4","article-title":"Parathyroidectomy improves cardiovascular risk factors in normocalcemic and hypercalcemic primary hyperparathyroidism","volume":"19","author":"Beysel","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/j.ando.2020.02.003_bib0715","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/cen.12952","article-title":"Parathyroidectomy in asymptomatic primary hyperparathyroidism reduces carotid intima-media thickness and arterial stiffness","volume":"84","author":"Cansu","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.02.003_bib0720","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.atherosclerosis.2011.05.010","article-title":"Large-artery stiffness: a reversible marker of cardiovascular risk in primary hyperparathyroidism","volume":"218","author":"Schillaci","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ando.2020.02.003_bib0725","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/hr.2010.232","article-title":"Pulse wave velocity in primary hyperparathyroidism and effect of surgical therapy","volume":"34","author":"Rosa","year":"2011","journal-title":"Hypertens Res"},{"key":"10.1016\/j.ando.2020.02.003_bib0730","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1530\/EC-18-0259","article-title":"The effect of surgery on fat mass, lipid and glucose metabolism in mild primary hyperparathyroidism","volume":"7","author":"Godang","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/j.ando.2020.02.003_bib0735","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0002-9343(88)80022-6","article-title":"Hypertension in pseudohypoparathyroidism type I","volume":"85","author":"Brickman","year":"1988","journal-title":"Am J Med"},{"key":"10.1016\/j.ando.2020.02.003_bib0740","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1210\/jc.2003-030028","article-title":"Growth hormone deficiency in pseudohypoparathyroidism type 1a: another manifestation of multihormone resistance","volume":"88","author":"Germain-Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0745","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1111\/cen.13927","article-title":"Cardiovascular findings in patients with nonsurgical hypoparathyroidism and pseudohypoparathyroidism: a cohort study","volume":"90","author":"Underbjerg","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.02.003_bib0750","doi-asserted-by":"crossref","first-page":"3024","DOI":"10.1210\/endo.136.7.7789328","article-title":"The hemodynamic basis for the cardiac effects of parathyroid hormone (PTH) and PTH-related protein","volume":"136","author":"Ogino","year":"1995","journal-title":"Endocrinology"},{"key":"10.1016\/j.ando.2020.02.003_bib0755","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1111\/cen.12948","article-title":"Pseudohypoparathyroidism\u00a0\u2013\u00a0epidemiology, mortality and risk of complications","volume":"84","author":"Underbjerg","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/j.ando.2020.02.003_bib0760","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.1210\/jc.2016-1477","article-title":"Epidemiology and health-related quality of life in hypoparathyroidism in Norway","volume":"101","author":"Astor","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0765","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0770","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/jbmr.1979","article-title":"Cardiovascular and renal complications to postsurgical hypoparathyroidism: a Danish nationwide controlled historic follow-up study","volume":"28","author":"Underbjerg","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2020.02.003_bib0775","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/jbmr.2501","article-title":"The epidemiology of nonsurgical hypoparathyroidism in Denmark: a nationwide case finding study","volume":"30","author":"Underbjerg","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2020.02.003_bib0780","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1210\/jc.2013-3352","article-title":"Hypocalcemic cardiomyopathy-different mechanisms in adult and pediatric cases","volume":"99","author":"Bansal","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0785","article-title":"Standards of care for hypoparathyroidism in adults","author":"Khan","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.ando.2020.02.003_bib0790","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1210\/jc.2015-3907","article-title":"Management of hypoparathyroidism: summary statement and guidelines","volume":"101","author":"Brandi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0795","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1002\/jbmr.3368","article-title":"Long-term complications in patients with hypoparathyroidism evaluated by biochemical findings: a case-control study","volume":"33","author":"Underbjerg","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2020.02.003_bib0800","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.ando.2020.02.003_bib0805","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1002\/jbmr.470","article-title":"The effect of adding PTH(1-84) to conventional treatment of hypoparathyroidism: a randomized, placebo-controlled study","volume":"26","author":"Sikjaer","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2020.02.003_bib0810","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/jc.2019-01010","article-title":"Safety and efficacy of 5 years of treatment with recombinant human parathyroid hormone in adults with hypoparathyroidism","volume":"104","author":"Mannstadt","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0815","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1002\/jbmr.1964","article-title":"PTH(1-84) replacement therapy in hypoparathyroidism: a randomized controlled trial on pharmacokinetic and dynamic effects after 6 months of treatment","volume":"28","author":"Sikjaer","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2020.02.003_bib0820","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/S0008-6363(97)00194-6","article-title":"Cardiovascular actions of parathyroid hormone and parathyroid hormone-related peptide","volume":"37","author":"Schluter","year":"1998","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.ando.2020.02.003_bib0825","doi-asserted-by":"crossref","first-page":"49","DOI":"10.14797\/mdcj-13-2-49","article-title":"The Parathyroid Gland and Heart Disease","volume":"13","author":"Brown","year":"2017","journal-title":"Methodist Debakey Cardiovasc J"},{"key":"10.1016\/j.ando.2020.02.003_bib0830","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1210\/er.2018-00220","article-title":"Clinical guidelines and PTH measurement: does assay generation matter?","volume":"40","author":"Smit","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/j.ando.2020.02.003_bib0835","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00198-016-3716-2","article-title":"Primary hyperparathyroidism: review and recommendations on evaluation, diagnosis, and management. A Canadian and international consensus","volume":"28","author":"Khan","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/j.ando.2020.02.003_bib0840","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/jc.2007-0219","article-title":"Surgery or surveillance for mild asymptomatic primary hyperparathyroidism: a prospective, randomized clinical trial","volume":"92","author":"Ambrogini","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0845","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1210\/jc.2008-2742","article-title":"Effect of surgery on cardiovascular risk factors in mild primary hyperparathyroidism","volume":"94","author":"Bollerslev","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0850","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1002\/jbmr.3177","article-title":"Effect of surgery versus observation: skeletal 5-year outcomes in a randomized trial of patients with primary HPT (the SIPH study)","volume":"32","author":"Lundstam","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/j.ando.2020.02.003_bib0855","doi-asserted-by":"crossref","first-page":"5415","DOI":"10.1210\/jc.2004-0028","article-title":"Randomized controlled clinical trial of surgery versus no surgery in patients with mild asymptomatic primary hyperparathyroidism","volume":"89","author":"Rao","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.ando.2020.02.003_bib0860","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.bone.2018.09.018","article-title":"Advances in the treatment of hypoparathyroidism with PTH 1-34","volume":"120","author":"Winer","year":"2019","journal-title":"Bone"},{"key":"10.1016\/j.ando.2020.02.003_bib0865","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1111\/bph.14028","article-title":"Repurposing a novel parathyroid hormone analogue to treat hypoparathyroidism","volume":"175","author":"Krishnan","year":"2018","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.ando.2020.02.003_bib0870","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1002\/jbmr.3824","article-title":"Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for Hypoparathyroidism","volume":"34","author":"Holten-Andersen","year":"2019","journal-title":"J Bone Miner Res"}],"container-title":["Annales d'Endocrinologie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003426620300263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T22:53:18Z","timestamp":1757717598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003426620300263"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":87,"journal-issue":{"issue":"3-4","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S0003426620300263"],"URL":"https:\/\/doi.org\/10.1016\/j.ando.2020.02.003","relation":{},"ISSN":["0003-4266"],"issn-type":[{"value":"0003-4266","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular consequences of parathyroid disorders in adults","name":"articletitle","label":"Article Title"},{"value":"Annales d'Endocrinologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ando.2020.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}]}}